EpimiRNA
Bicoll © Kai Lamottke
Bicoll © Kai Lamottke

Partner 6 - Universitätsklinikum Erlangen - UKER

 

Hajo Hamer

 

Prof. Hajo Hamer

Principal Investigator

Phone: +49 9131 85-39116

Fax: +49 9131 85-36469

undefinedE-Mail

 

undefinedPubMed

Universitätsklinikum Erlangen

Maximiliansplatz 2

91054 Erlangen

Germany

undefinedWebsite

 

 

 

 

 

 

EpimiRNA Team UKER

 

Mareike Hagge

Johannes Lang

Dr. Mareike Hagge

undefinedE-Mail

Dr. Johannes Lang

undefinedE-Mail

 

 

 

 

 

Institute presentation

The Erlangen epilepsy center (undefinedhttp://www.epilepsiezentrum.uk-erlangen.de/) embedded in the Department of Neurology of the University of Erlangen (undefinedhttp://www.neurologie.uk-erlangen.de/) is one of the largest epilepsy centers in Germany. It offers all diagnostic and therapeutic options to patients with epilepsy including invasive EEG recordings and performs more than 50 resective epilepsy surgeries a year which amounts to more than 700 epilepsy surgeries in the last 15 years. In addition, the epilepsy center has a track record of more than 200 vagalnerve-stimulation (VNS) surgeries and implants 15-20 VNS every year. The Department of Neurology includes a large 12 bed NICU equipped with multimodal monitoring. This includes microdialysis among other invasive monitoring modalities and 6 beds with video-EEE monitoring capacity (including intracranial EEG).

The UKER has a dedicated academic team of the epileptologists and neurointensivists with numerous publications in the field of neurointensive medicine and epileptology. There is a close cooperation between both teams with joint studies covering the epileptic aspects in neurointensive care. The scientific expertise comprises electrophysiological analyses including subdural EEG and MEG. The team also studies immunological alterations in human epilepsies. 

EpimiRNA Team

EpimiRNA Work packages

EpimiRNA Work packages
Home
Top

Newsletter Subscription

EpimiRNA on @twitter

News Section

Great success of the EpimiRNA consortium resulting in EMBO publication!

Read...

Read more

Social Media

Twitter Google Plus Facebook
Home
Top